Raymond James & Associates’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,735
| Closed | -$131K | – | 3806 |
|
|
2023
Q3 | $131K | Sell |
10,735
-13,345
| -55% | -$162K | ﹤0.01% | 3524 |
|
|
2023
Q2 | $302K | Buy |
+24,080
| New | +$302K | ﹤0.01% | 3227 |
|
|
2023
Q1 | – | Sell |
-10,273
| Closed | -$125K | – | 3850 |
|
|
2022
Q4 | $125K | Buy |
+10,273
| New | +$125K | ﹤0.01% | 3556 |
|
|
2022
Q1 | – | Sell |
-27,687
| Closed | -$320K | – | 3985 |
|
|
2021
Q4 | $320K | Buy |
27,687
+1,459
| +6% | +$16.9K | ﹤0.01% | 3381 |
|
|
2021
Q3 | $250K | Sell |
26,228
-8,389
| -24% | -$80K | ﹤0.01% | 3520 |
|
|
2021
Q2 | $334K | Sell |
34,617
-76,229
| -69% | -$735K | ﹤0.01% | 3340 |
|
|
2021
Q1 | $1.1M | Buy |
110,846
+33,199
| +43% | +$328K | ﹤0.01% | 2442 |
|
|
2020
Q4 | $1.79M | Sell |
77,647
-3,982
| -5% | -$92K | ﹤0.01% | 1948 |
|
|
2020
Q3 | $1.15M | Sell |
81,629
-15,670
| -16% | -$221K | ﹤0.01% | 2094 |
|
|
2020
Q2 | $1.47M | Buy |
97,299
+7,130
| +8% | +$108K | ﹤0.01% | 1908 |
|
|
2020
Q1 | $833K | Buy |
90,169
+6,700
| +8% | +$61.9K | ﹤0.01% | 2100 |
|
|
2019
Q4 | $813K | Buy |
83,469
+10,522
| +14% | +$102K | ﹤0.01% | 2398 |
|
|
2019
Q3 | $585K | Buy |
72,947
+17,020
| +30% | +$136K | ﹤0.01% | 2538 |
|
|
2019
Q2 | $698K | Buy |
55,927
+5,747
| +11% | +$71.7K | ﹤0.01% | 2430 |
|
|
2019
Q1 | $682K | Buy |
50,180
+12,134
| +32% | +$165K | ﹤0.01% | 2445 |
|
|
2018
Q4 | $364K | Sell |
38,046
-14,666
| -28% | -$140K | ﹤0.01% | 2748 |
|
|
2018
Q3 | $637K | Sell |
52,712
-2,449
| -4% | -$29.6K | ﹤0.01% | 2532 |
|
|
2018
Q2 | $862K | Sell |
55,161
-964
| -2% | -$15.1K | ﹤0.01% | 2317 |
|
|
2018
Q1 | $844K | Sell |
56,125
-136,853
| -71% | -$2.06M | ﹤0.01% | 2253 |
|
|
2017
Q4 | $2.78M | Buy |
192,978
+2,414
| +1% | +$34.7K | 0.01% | 1474 |
|
|
2017
Q3 | $2.87M | Buy |
+190,564
| New | +$2.87M | 0.01% | 1392 |
|
|
2016
Q2 | – | Sell |
-21,324
| Closed | -$180K | – | 2925 |
|
|
2016
Q1 | $180K | Sell |
21,324
-3,676
| -15% | -$31K | ﹤0.01% | 2593 |
|
|
2015
Q4 | $243K | Buy |
+25,000
| New | +$243K | ﹤0.01% | 2270 |
|